Title:
C型肝炎ウイルスの阻害剤、それを使用する組成物および治療法
Document Type and Number:
Japanese Patent JP2006517960
Kind Code:
A
Abstract:
The invention relates to methods of inhibiting HCV viral replication activity comprising contacting an HCV polymerase with a therapeutically effective amount of a hydroxamate MMP inhibitor, and compositions comprising the same.
More Like This:
| WO/2006/077724 | CANCER VACCINE PREPARATION |
| JP2006505490 | Dosing regimen for gemcitabine HCV treatment |
| JP2008510481 | Methods and compositions for Alzheimer's disease |
Inventors:
Rohit Dugal
Amy Karen Pattic
Weydon Hao
Colleen Jill Harrich
Ayan Shah
Way Liu
Amy Karen Pattic
Weydon Hao
Colleen Jill Harrich
Ayan Shah
Way Liu
Application Number:
JP2006502443A
Publication Date:
August 03, 2006
Filing Date:
February 06, 2004
Export Citation:
Assignee:
Pfizer Inc.
International Classes:
A61K45/00; A61K31/00; A61K31/16; A61K31/165; A61K31/166; A61K31/167; A61K31/18; A61K31/197; A61K31/198; A61K31/216; A61K31/245; A61K31/341; A61K31/351; A61K31/381; A61K31/40; A61K31/404; A61K31/4172; A61K31/4196; A61K31/42; A61K31/427; A61K31/437; A61K31/44; A61K31/4409; A61K31/443; A61K31/4439; A61K31/445; A61K31/451; A61K31/454; A61K31/4545; A61K31/495; A61K31/496; A61K31/4965; A61K31/513; A61K31/5375; A61K31/5377; A61K31/54; A61K31/541; A61K31/553; A61K31/675; A61P1/16; A61P31/14; A61P43/00; C07C259/06; C07C317/44; C07C323/61; C07D241/04; C07D261/08; C07D417/12
Attorney, Agent or Firm:
Chika Takagi
Junji Yuda
Shoji Miwa
Junji Yuda
Shoji Miwa